Empirical Therapy of Community-Acquired Pneumonia
A 58-year-old man presents with 3 days of fever, rigors and productive cough. He has not been hospitalised or received antibiotics in the past year. Temperature is 38.9 °C and oxygen saturation is 92% on room air. He is fully orientated, and chest radiography shows right lower lobe consolidation. He is admitted to a general medical ward. Which of the following is the most appropriate empirical antibiotic regimen?
- A.Meropenem plus azithromycin
- B.Vancomycin plus azithromycin
- C.Ceftriaxone plus azithromycinCorrect
- D.Oral amoxicillin alone
Explanation
For a patient admitted to a general ward with community-acquired pneumonia, the recommended empirical regimen is a third-generation cephalosporin such as ceftriaxone combined with a macrolide such as azithromycin, or alternatively a respiratory fluoroquinolone as monotherapy. Ceftriaxone covers Streptococcus pneumoniae, which the rust-coloured sputum and lobar consolidation suggest, together with Haemophilus influenzae and most Moraxella species, while azithromycin covers the atypical organisms Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila, which cannot be reliably excluded clinically. Combination therapy including a macrolide is associated with lower mortality in hospitalised pneumonia, partly through atypical coverage and partly through immunomodulatory effects. His CURB-65 score is 1 for the respiratory rate criterion, and hypoxaemia justifies admission rather than outpatient treatment, which is why oral amoxicillin alone is inadequate here even though it is appropriate for low-risk outpatients. Vancomycin adds cover for meticillin-resistant Staphylococcus aureus, which is only indicated when there are risk factors such as prior colonisation, recent hospitalisation, necrotising or post-influenza pneumonia. Meropenem is reserved for suspected Pseudomonas aeruginosa or multidrug-resistant Gram-negative infection, typically in bronchiectasis, recent broad-spectrum antibiotics or hospital-acquired disease, and its unnecessary use drives resistance. Therapy should be de-escalated once cultures return and continued for a minimum of 5 days with clinical stability for 48 hours.
Why each option
- A.
- Meropenem is reserved for suspected Pseudomonas or multidrug-resistant organisms and is excessive for uncomplicated community-acquired pneumonia.
- B.
- Vancomycin is only added when meticillin-resistant Staphylococcus aureus risk factors are present, and it lacks Gram-negative cover.
- C.
- Correct. Ceftriaxone plus a macrolide covers typical and atypical pathogens and is standard for non-severe inpatient community-acquired pneumonia.
- D.
- Oral amoxicillin alone suits low-risk outpatients but is inadequate for a hypoxaemic admitted patient and lacks atypical cover.
Reference: ATS/IDSA Clinical Practice Guideline on Diagnosis and Treatment of Adults with Community-acquired Pneumonia, 2019
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank